{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:55:02Z","timestamp":1787007302286,"version":"build-2736575974"},"reference-count":29,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["grant agreement No. 777363"],"award-info":[{"award-number":["grant agreement No. 777363"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2022,12,2]]},"DOI":"10.1080\/14760584.2022.2137144","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:30:02Z","timestamp":1666225802000},"page":"1701-1710","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1008-3922","authenticated-orcid":false,"given":"Javier","family":"D\u00edez-Domingo","sequence":"first","affiliation":[{"name":"Fundaci\u00f3n para el Fomento de la Investigaci\u00f3n Sanitaria y Biom\u00e9dica de la Comunidad Valenciana (Fisabio), Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Torcel-Pagnon","sequence":"additional","affiliation":[{"name":"Modeling, Epidemiology and Data Science, Sanofi, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Carmona","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n para el Fomento de la Investigaci\u00f3n Sanitaria y Biom\u00e9dica de la Comunidad Valenciana (Fisabio), Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes, Sorbonne Paris Cit\u00e9, Inserm CIC 1417, Assistance Publique Hopitaux de Paris (APHP), CIC Cochin-Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8623-3478","authenticated-orcid":false,"given":"Ga\u00ebl","family":"Dos Santos","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Functional Area of Clinical Pathways and Epidemiology, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mendel","family":"Haag","sequence":"additional","affiliation":[{"name":"Center of Outcomes Research and Epidemiology, Medical Affairs, Seqirus, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Stuurman","sequence":"additional","affiliation":[{"name":"P95 Epidemiology & Pharmacovigilance, Heverlee, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Nauta","sequence":"additional","affiliation":[{"name":"Abbott Healthcare Products B.V, CP Weesp, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Vannacci","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-2641","authenticated-orcid":false,"given":"Simon","family":"de Lusignan","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Del Rey","sequence":"additional","affiliation":[{"name":"Synapse Research Management Partners SL (SYNAPSE), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-3952","authenticated-orcid":false,"given":"Miriam","family":"Levi","sequence":"additional","affiliation":[{"name":"Azienda USL Toscana Centro, Dipartimento di Prevenzione, Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8959-2123","authenticated-orcid":false,"given":"Bruno","family":"Lina","sequence":"additional","affiliation":[{"name":"VirPath Research Laboratory, University Claude Bernard Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1149-3835","authenticated-orcid":false,"given":"Stefania","family":"Bellino","sequence":"additional","affiliation":[{"name":"Istituto Superiore Di Sanita (ISS), ROMA, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Nye","sequence":"additional","affiliation":[{"name":"Confederation Of Meningitis Organisations Ltd (CoMO), Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Neels","sequence":"additional","affiliation":[{"name":"International Association for Biological Standardization for Europe, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Nohynek","sequence":"additional","affiliation":[{"name":"Finnish Institute for Health and Welfare, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Mah\u00e9","sequence":"additional","affiliation":[{"name":"Modeling, Epidemiology and Data Science, Sanofi, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"issue":"4","key":"cit0001","first-page":"549","volume":"78","author":"Buse K","year":"2000","journal-title":"Bull World Health Organ"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1400473111"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2014.0150"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2020.11.010"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.073"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12335"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1126\/science.abh3986"},{"issue":"2","key":"cit0008","doi-asserted-by":"crossref","first-page":"e10214","DOI":"10.1002\/lrh2.10214","volume":"4","author":"Lovestone S","year":"2020","journal-title":"Learn Health Syst"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.07.005"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1812630"},{"issue":"1","key":"cit0011","first-page":"49","volume":"27","author":"Tille F","year":"2021","journal-title":"Eurohealth"},{"key":"cit0012","unstructured":"European Centre for Disease Prevention and Control (ECDC). Factsheet about seasonal influenza. (https:\/\/www.ecdc.europa.eu\/en\/seasonal-influenza\/facts\/factsheet 2020)"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12351"},{"key":"cit0014","unstructured":"Committee for Medicinal Products for Human Use. Guideline on Influenza Vaccines \u2013 Non-clinical and Clinical Module. EMA\/CHMP\/VWP\/457259\/2014 . 2016;44(July):1-31 (London, UK: European Medicines Agency) . 2016."},{"key":"cit0015","unstructured":"Working Group under the EU\/EEA NITAG Collaboration. Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of Laboratory-Confirmed influenza in individuals aged 18 years and over. (https:\/\/www.ecdc.europa.eu\/en\/news-events\/seasonal-influenza-vaccines-systematic-review-efficacy 2020)"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248943"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.2807\/ese.17.39.20281-en"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.02.039"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.081"},{"key":"cit0020","unstructured":"DRIVE consortium. DRIVE \u2013 development of robust and innovative vaccine effectiveness \u2013 increasing understanding of influenza vaccine effectiveness in Europe. (https:\/\/www.drive-eu.org AccessedCited 2020 Nov 9 2020)"},{"key":"cit0021","unstructured":"DRIVE consortium. D7.1.3 core protocol for type\/brand- specific influenza vaccine effectiveness studies \u2013 test-negative design. Accessed 15 February 2022 https:\/\/www.drive-eu.org\/wp-content\/uploads\/2021\/09\/DRIVE_D7.1.3_TND-generic-protocol-2021-22_clean_final.pdf"},{"key":"cit0022","unstructured":"DRIVE consortium. THL DRIVE protocol, season 2021\/22. Accessed 15 February 2022 https:\/\/www.drive-eu.org\/wp-content\/uploads\/2021\/10\/D7.2.3-Core-protocol-for-type-and-brand-specific-influenza-vaccine-effectiveness-studies-population-based-database-cohort-studies_THL-protocol-2021_22.doc.pdf"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.10.2000153"},{"key":"cit0024","unstructured":"European Medicines Agency. Vaccines working party. https:\/\/www.ema.europa.eu\/en\/committees\/working-parties-other-groups\/chmp\/vaccines-working-party"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.07.063"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.05.059"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.21820\/23987073.2018.12.82"},{"key":"cit0028","unstructured":"DRIVE Independent Scientific Committee. DRIVE ISC reactive statement towards PPP hesitancy. (2019)"},{"key":"cit0029","unstructured":"European Centre for Disease Prevention and Control (ECDC). Vaccine Effectiveness, Burden and Impact Studies (VEBIS) of Covid-19 and Influenza. (2021)"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2022.2137144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:28:30Z","timestamp":1701217710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2022.2137144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,2]]}},"alternative-id":["10.1080\/14760584.2022.2137144"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2022.2137144","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-05-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}